Kevin Kelnar

机构：R&D Systems (United States)

发表论文 68 篇 · 总被引 8002 次 · h-index 18

代表论文

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours (2020 · British Journal of Cancer · 被引 979)
PDL1 Regulation by p53 via miR-34 (2015 · JNCI Journal of the National Cancer Institute · 被引 694)
A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer (2014 · Oncogene · 被引 211)
Quantification of Therapeutic miRNA Mimics in Whole Blood from Nonhuman Primates (2014 · Analytical Chemistry · 被引 71)
In-Depth Analysis Shows Synergy between Erlotinib and miR-34a (2014 · PLoS ONE · 被引 69)
Synergy between next generation EGFR tyrosine kinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer (2017 · Lung Cancer · 被引 40)